AAAAAA

   
Results: 1-20 |
Results: 20
TISSUE FACTOR PATHWAY INHIBITOR AND ANTI-FXA KINETIC PROFILES OF A NEW LOW-MOLECULAR-MASS HEPARIN, BEMIPARIN, AT THERAPEUTIC SUBCUTANEOUS DOSES
Authors: FALKON L GARI M BARBANOJ M AMIRAL J FONTCUBERTA J
Citation: L. Falkon et al., TISSUE FACTOR PATHWAY INHIBITOR AND ANTI-FXA KINETIC PROFILES OF A NEW LOW-MOLECULAR-MASS HEPARIN, BEMIPARIN, AT THERAPEUTIC SUBCUTANEOUS DOSES, Blood coagulation & fibrinolysis, 9(2), 1998, pp. 137-141
PHARMACODYNAMIC ASSESSMENT OF THE EFFICACY OF SINGLE AND MULTIPLE DOSES OF EBASTINE, CETIRIZINE AND LORATADINE AGAINST HISTAMINE-INDUCED CUTANEOUS CHALLENGE IN HEALTHY-VOLUNTEERS
Authors: GISPERT J ANTONIJOAN R BARBANOJ M GICH I MORTE A GARCIA E ESBRI R LURIA X
Citation: J. Gispert et al., PHARMACODYNAMIC ASSESSMENT OF THE EFFICACY OF SINGLE AND MULTIPLE DOSES OF EBASTINE, CETIRIZINE AND LORATADINE AGAINST HISTAMINE-INDUCED CUTANEOUS CHALLENGE IN HEALTHY-VOLUNTEERS, Journal of allergy and clinical immunology, 101(1), 1998, pp. 920-920
CHRONIC EFFECTS OF DOPAMINERGIC REPLACEMENT ON COGNITIVE FUNCTION IN PARKINSONS-DISEASE - A ONE-YEAR FOLLOW-UP-STUDY ON UNTREATED PATIENTS COMPARING LEVODOPA AND PERGOLIDE
Authors: KULISEVSKY J GARCIASANCHEZ C LOPEZVILLEGAS D BERTHIER ML GIRONELL A BARBANOJ M PASCUALSEDANO B
Citation: J. Kulisevsky et al., CHRONIC EFFECTS OF DOPAMINERGIC REPLACEMENT ON COGNITIVE FUNCTION IN PARKINSONS-DISEASE - A ONE-YEAR FOLLOW-UP-STUDY ON UNTREATED PATIENTS COMPARING LEVODOPA AND PERGOLIDE, Neurology, 50(4), 1998, pp. 5041-5041
A DOUBLE-BLIND PLACEBO-CONTROLLED COMPARATIVE TRIAL OF GABAPENTIN ANDPROPRANOLOL IN PATIENTS WITH ESSENTIAL TREMOR
Authors: GIRONELL A KULISEVSKY J BARBANOJ M LOPEZVILLEGAS D HERNANDEZ G PASCUALSEDANO B
Citation: A. Gironell et al., A DOUBLE-BLIND PLACEBO-CONTROLLED COMPARATIVE TRIAL OF GABAPENTIN ANDPROPRANOLOL IN PATIENTS WITH ESSENTIAL TREMOR, Neurology, 50(4), 1998, pp. 7006-7006
DETERMINATION OF CAPTOPRIL IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOR PHARMACOKINETIC STUDIES
Authors: ARROYO C LOPEZCALULL C GARCIACAPDEVILA L GICH I BARBANOJ M BONAL J
Citation: C. Arroyo et al., DETERMINATION OF CAPTOPRIL IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOR PHARMACOKINETIC STUDIES, Journal of chromatography B. Biomedical sciences and applications, 688(2), 1997, pp. 339-344
SPECTRUM OF ALCOHOL-INDUCED MYOCARDIAL DAMAGE DETECTED BY INDIUM-111-LABELED MONOCLONAL ANTIMYOSIN ANTIBODIES
Authors: BALLESTER M MARTI V CARRIO I OBRADOR D MOYA C PONSLLADO G BERNA L LAMICH R AYMAT MR BARBANOJ M GUARDIA J CARRERAS F UDINA C AUGE JM MARRUGAT J PERMANYER G CARALPSRIERA JM
Citation: M. Ballester et al., SPECTRUM OF ALCOHOL-INDUCED MYOCARDIAL DAMAGE DETECTED BY INDIUM-111-LABELED MONOCLONAL ANTIMYOSIN ANTIBODIES, Journal of the American College of Cardiology, 29(1), 1997, pp. 160-167
TFPI AND ANT-FXA KINETIC PROFILES OF A NEW LMMH (RO-11.ROVI), AT SC THERAPEUTIC DOSES
Authors: FALKON L GARI M BARBANOJ M AMIRAL J FONTCUBERTA J
Citation: L. Falkon et al., TFPI AND ANT-FXA KINETIC PROFILES OF A NEW LMMH (RO-11.ROVI), AT SC THERAPEUTIC DOSES, Thrombosis and haemostasis, 1997, pp. 1173-1173
PHARMACOKINETICS AND TOLERABILITY OF A NEW LOW-MOLECULAR-MASS HEPARIN(RO-11) IN HEALTHY-VOLUNTEERS - A DOSE-FINDING STUDY WITHIN THE THERAPEUTIC RANGE
Authors: FALKON L BAYES M FRONTERA G GARI M BARBANOJ M FONTCUBERTA J
Citation: L. Falkon et al., PHARMACOKINETICS AND TOLERABILITY OF A NEW LOW-MOLECULAR-MASS HEPARIN(RO-11) IN HEALTHY-VOLUNTEERS - A DOSE-FINDING STUDY WITHIN THE THERAPEUTIC RANGE, Thrombosis and haemostasis, 77(1), 1997, pp. 133-136
THE HIGHER MOTOR-PERFORMANCE OF THE DOMINANT HAND TENDS TO DISAPPEAR UNDER ALCOHOL EFFECTS
Authors: HERNANDEZCOLLADOS A SANCHEZTURET M ARNAU J GARCIAGEA C BARBANOJ M
Citation: A. Hernandezcollados et al., THE HIGHER MOTOR-PERFORMANCE OF THE DOMINANT HAND TENDS TO DISAPPEAR UNDER ALCOHOL EFFECTS, International journal of psychophysiology, 25(1), 1997, pp. 45-45
TIME PERCEPTION IS DISTORTED UNDER ALCOHOL EFFECTS, EVEN AT BAC VALUENEAR TO ZERO
Authors: HERNANDEZCOLLADOS A SANCHEZTURET M ANTONIJOAN R MASSANA E BARBANOJ M
Citation: A. Hernandezcollados et al., TIME PERCEPTION IS DISTORTED UNDER ALCOHOL EFFECTS, EVEN AT BAC VALUENEAR TO ZERO, International journal of psychophysiology, 25(1), 1997, pp. 45-46
QUANTITATIVE ASSESSMENT OF PARKINSONS-DISEASE TREMOR RESPONSE TO THEOPHYLLINE AND PLACEBO - A DOUBLE-BLIND RANDOMIZED CROSSOVER STUDY
Authors: GIRONELL A KULISEVSKY J BARBANOJ M ANTONIJOAN R MASSANA E
Citation: A. Gironell et al., QUANTITATIVE ASSESSMENT OF PARKINSONS-DISEASE TREMOR RESPONSE TO THEOPHYLLINE AND PLACEBO - A DOUBLE-BLIND RANDOMIZED CROSSOVER STUDY, Neurology, 48(3), 1997, pp. 3093-3093
SEX-RELATED PHARMACOKINETIC AND PHARMACODYNAMIC VARIATIONS OF LISINOPRIL
Authors: SAENZCAMPOS D BAYES MC MASANA E MARTIN S BARBANOJ M JANE F
Citation: D. Saenzcampos et al., SEX-RELATED PHARMACOKINETIC AND PHARMACODYNAMIC VARIATIONS OF LISINOPRIL, Methods and findings in experimental and clinical pharmacology, 18(8), 1996, pp. 533-538
NEUROPSYCHOLOGICAL PERFORMANCE IN STABLE AND FLUCTUATING PARKINSONS-DISEASE PATIENTS AT 3 DIFFERENT LEVODOPA PLASMA-LEVELS
Authors: KULISEVSKY J AVILA A BARBANOJ M ANTONIJOAN R BERTHIER ML
Citation: J. Kulisevsky et al., NEUROPSYCHOLOGICAL PERFORMANCE IN STABLE AND FLUCTUATING PARKINSONS-DISEASE PATIENTS AT 3 DIFFERENT LEVODOPA PLASMA-LEVELS, Neurology, 46(2), 1996, pp. 1098-1098
ACUTE EFFECTS OF LEVODOPA ON NEUROPSYCHOLOGICAL PERFORMANCE IN STABLEAND FLUCTUATING PARKINSONS-DISEASE PATIENTS AT DIFFERENT LEVODOPA PLASMA-LEVELS
Authors: KULISEVSKY J AVILA A BARBANOJ M ANTONIJOAN R BERTHIER ML GIRONELL A
Citation: J. Kulisevsky et al., ACUTE EFFECTS OF LEVODOPA ON NEUROPSYCHOLOGICAL PERFORMANCE IN STABLEAND FLUCTUATING PARKINSONS-DISEASE PATIENTS AT DIFFERENT LEVODOPA PLASMA-LEVELS, Brain, 119, 1996, pp. 2121-2132
LEVODOPA DOES NOT AGGRAVATE POSTURAL TREMOR IN PARKINSONS-DISEASE
Authors: KULISEVSKY J AVILA A BARBANOJ M ANTONIJOAN R TORRES J ARCELUS R
Citation: J. Kulisevsky et al., LEVODOPA DOES NOT AGGRAVATE POSTURAL TREMOR IN PARKINSONS-DISEASE, Clinical neuropharmacology, 18(5), 1995, pp. 435-442
KINETIC-BEHAVIOR OF THE TFPI AND ANTI-FXA EFFECTS, AFTER THE INJECTION OF A NEW LMWH (RO-11) IN HEALTHY-SUBJECTS
Authors: FALKON L SAENZCAMPOS D GARI M ANTONIJOAN R BARBANOJ M FONTCUBERTA J
Citation: L. Falkon et al., KINETIC-BEHAVIOR OF THE TFPI AND ANTI-FXA EFFECTS, AFTER THE INJECTION OF A NEW LMWH (RO-11) IN HEALTHY-SUBJECTS, Thrombosis and haemostasis, 73(6), 1995, pp. 971-971
KINETIC-BEHAVIOR OF THE TFPI AND ANTI-FXA EFFECTS, AFTER THE INJECTION OF A LMWH (RO-11) IN HEALTHY-SUBJECTS
Authors: FALKON L GARI M SAENZCAMPOS D ANTONIJOAN R BARBANOJ M FONTCUBERTA J
Citation: L. Falkon et al., KINETIC-BEHAVIOR OF THE TFPI AND ANTI-FXA EFFECTS, AFTER THE INJECTION OF A LMWH (RO-11) IN HEALTHY-SUBJECTS, Thrombosis and haemostasis, 73(4), 1995, pp. 728-729
BIOAVAILABILITY AND PHARMACOKINETICS OF A NEW LOW-MOLECULAR-WEIGHT HEPARIN (RO-11) - A 3-WAY CROSS-OVER STUDY IN HEALTHY-VOLUNTEERS
Authors: FALKON L SAENZCAMPOS D ANTONIJOAN R MARTIN S BARBANOJ M FONTCUBERTA J
Citation: L. Falkon et al., BIOAVAILABILITY AND PHARMACOKINETICS OF A NEW LOW-MOLECULAR-WEIGHT HEPARIN (RO-11) - A 3-WAY CROSS-OVER STUDY IN HEALTHY-VOLUNTEERS, Thrombosis research, 78(1), 1995, pp. 77-86
DOUBLE-BLIND TRIAL OF FLUMAZENIL IN HEMIBALLISMUS
Authors: KULISEVSKY J AVILA A BERTHIER ML BARBANOJ M
Citation: J. Kulisevsky et al., DOUBLE-BLIND TRIAL OF FLUMAZENIL IN HEMIBALLISMUS, Clinical neuropharmacology, 17(5), 1994, pp. 470-472
EFFECTS OF BENZODIAZEPINE AGONISTS AND ANTAGONISTS ON THE PROCESS OF HABITUATION DURING EXPOSURE TREATMENTS
Authors: SANCHEZ R BARBANOJ M FERNANDEZTERUEL A ESCORIHUELA RM TOBENA A
Citation: R. Sanchez et al., EFFECTS OF BENZODIAZEPINE AGONISTS AND ANTAGONISTS ON THE PROCESS OF HABITUATION DURING EXPOSURE TREATMENTS, Neuropsychopharmacology, 9(2), 1993, pp. 190000123-190000123
Risultati: 1-20 |